Literature DB >> 26213381

Potency and penetration of telavancin in staphylococcal biofilms.

Kelly R Kirker1, Steve T Fisher2, Garth A James2.   

Abstract

Due to the emergence of staphylococcal biofilm infections, the need for advanced antibiotics is crucial. The aim of this investigation was to evaluate the potency and penetration of telavancin against staphylococcal biofilms using two different biofilm models. Multiple staphylococcal strains, including meticillin-sensitive Staphylococcus aureus ATCC 29213, vancomycin-intermediate S. aureus ATCC 700787, heterogeneously vancomycin-intermediate S. aureus ATCC 700698 and meticillin-sensitive Staphylococcus epidermidis ATCC 12228, were grown and treated in drip-flow reactors to determine log reductions due to telavancin treatment. After 3 days of biofilm growth and 24 h of treatment, mean log reductions for telavancin ranged from 1.65 to 2.17 depending on the bacterial strain tested. Penetration was evaluated qualitatively using confocal scanning laser microscopy to image the infiltration of fluorescently labelled antibiotic into a staphylococcal biofilm grown in a flow cell. Fluorescently labelled telavancin rapidly penetrated the biofilms with no alteration in the biofilm structure.
Copyright © 2015 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.

Entities:  

Keywords:  Biofilm; Staphylococcal; Telavancin

Mesh:

Substances:

Year:  2015        PMID: 26213381     DOI: 10.1016/j.ijantimicag.2015.05.022

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  7 in total

1.  Measuring Antimicrobial Efficacy against Biofilms: a Meta-analysis.

Authors:  Philip S Stewart; Albert E Parker
Journal:  Antimicrob Agents Chemother       Date:  2019-04-25       Impact factor: 5.191

2.  Evaluation of Antibiotics Active against Methicillin-Resistant Staphylococcus aureus Based on Activity in an Established Biofilm.

Authors:  Daniel G Meeker; Karen E Beenken; Weston B Mills; Allister J Loughran; Horace J Spencer; William B Lynn; Mark S Smeltzer
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

3.  Evaluation of Telavancin Alone and Combined with Ceftaroline or Rifampin against Methicillin-Resistant Staphylococcus aureus in an In Vitro Biofilm Model.

Authors:  Seyedehameneh Jahanbakhsh; Nivedita B Singh; Juwon Yim; Warren E Rose; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2018-07-27       Impact factor: 5.191

Review 4.  The crafty opponent: the defense systems of Staphylococcus aureus and response measures.

Authors:  Hongjie Hou; Yang Li; Yuefei Jin; Shuaiyin Chen; Jinzhao Long; Guangcai Duan; Haiyan Yang
Journal:  Folia Microbiol (Praha)       Date:  2022-02-12       Impact factor: 2.099

Review 5.  Convergence of Staphylococcus aureus Persister and Biofilm Research: Can Biofilms Be Defined as Communities of Adherent Persister Cells?

Authors:  Elaine M Waters; Sarah E Rowe; James P O'Gara; Brian P Conlon
Journal:  PLoS Pathog       Date:  2016-12-29       Impact factor: 6.823

6.  Development of Cefotaxime Impregnated Chitosan as Nano-antibiotics: De Novo Strategy to Combat Biofilm Forming Multi-drug Resistant Pathogens.

Authors:  Bushra Jamil; Huma Habib; Shahid A Abbasi; Ayesha Ihsan; Habib Nasir; Muhammad Imran
Journal:  Front Microbiol       Date:  2016-03-18       Impact factor: 5.640

Review 7.  Shedding light on biology of bacterial cells.

Authors:  Johannes P Schneider; Marek Basler
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2016-11-05       Impact factor: 6.237

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.